Related Experiment Video
Updated: May 16, 2026
04:46
Differentiation and Imaging of Brown Adipocytes from the Stromal Vascular Fraction of Interscapular Adipose Tissue from Newborn Mice
Published on: February 3, 2023
Biochemical changes induced by strontium ranelate in differentiating adipocytes
Christopher Vidal1, Krishanthi Gunaratnam, Jessica Tong
1Ageing Bone Research Program, Sydney Medical School Nepean, The University of Sydney, Penrith, NSW 2750, Australia. chris.vidal@sydney.edu.au
Biochimie
|November 29, 2012
Summary
Strontium ranelate (SrRN) treatment for osteoporosis reduces adipogenesis in mesenchymal stem cells (MSCs). This finding suggests SrRN may improve the bone marrow environment for bone formation.
Area of Science:
- Bone Biology
- Stem Cell Differentiation
- Pharmacology
Background:
- Osteoporosis involves decreased bone formation due to mesenchymal stem cell (MSC) shifts towards fat (adipogenic) differentiation.
- This shift creates a harmful fatty (lipotoxic) environment in the bone marrow.
- Strontium ranelate (SrRN) is an osteoporosis treatment with bone-building effects, but its impact on marrow adipocyte factors is unclear.
Purpose of the Study:
- To investigate how SrRN affects adipogenic differentiation of MSCs.
- To understand SrRN's influence on adipokines and the bone marrow microenvironment.
Main Methods:
- Primary human MSCs were induced to differentiate into fat cells (adipocytes).
- Cells were treated with varying concentrations of SrRN (1-2 mM) during differentiation.
- Adipogenic markers and adipokine (cell signaling protein) expression were analyzed.
Main Results:
- SrRN inhibited adipogenesis in a dose-dependent manner.
- SrRN decreased the expression of key adipogenic markers.
- SrRN altered the profile of expressed adipokines.
Conclusions:
- SrRN negatively impacts adipocyte differentiation in vitro.
- These biochemical changes induced by SrRN may create a more favorable environment for bone formation within the marrow.
